West Branch Capital’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$301 Hold
2
﹤0.01% 334
2026
Q1
$185 Hold
2
﹤0.01% 366
2025
Q4
$205 Hold
2
﹤0.01% 402
2025
Q3
$125 Hold
2
﹤0.01% 447
2025
Q2
$105 Hold
2
﹤0.01% 467
2025
Q1
$86 Hold
2
﹤0.01% 520
2024
Q4
$62 Hold
2
﹤0.01% 543
2024
Q3
$46 Buy
+2
New +$57 ﹤0.01% 584

Other funds holding GH

West Branch Capital's GH Position: Q2 2026 in Review

West Branch Capital held its Guardant Health (GH) position steady in Q2 2026 at 2 shares worth $301. The position accounts for ﹤0.01% of the portfolio, ranked #334.

West Branch Capital first reported a position in GH in Q3 2024 and has held it in 8 quarters since. 46 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • West Branch Capital held 2 shares of Guardant Health worth $301 as of Q2 2026.
  • West Branch Capital left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up ﹤0.01% of West Branch Capital's portfolio in Q2 2026, its #334 holding.
  • West Branch Capital first reported a position in Guardant Health in Q3 2024 and has held it in 8 quarters since.
  • 46 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.